Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on October 25, 2017, to report its financial results for the third quarter ended September 30, 2017. This filing primarily serves to furnish a press release detailing these results, which is incorporated by reference as Exhibit 99.1. While the 8-K itself does not contain the specific financial figures, it directs investors to the furnished press release for detailed information on the company's performance during the quarter. Investors should review Exhibit 99.1 to understand the company's revenue, earnings, and other key financial metrics for the period, as well as any forward-looking guidance or commentary provided by management.
Key Highlights
- 1Elevance Health (Anthem, Inc.) announced its third-quarter 2017 financial results via an 8-K filing.
- 2The core of the filing is the furnishing of a press release (Exhibit 99.1) containing the detailed financial results.
- 3The press release covers the third quarter ended September 30, 2017.
- 4This 8-K filing does not contain the actual financial results within the report itself; investors must refer to the attached press release.
- 5Information furnished under Item 2.02 and Exhibit 99.1 is not considered 'filed' for Section 18 purposes.
- 6This filing is primarily an informational disclosure of previously released financial results.